Product code QYW— Cardiovascular

HEARTRAC ECG MONITORING SYSTEM

Classification name
Hospital Cardiac Telemetry
Device class
Class 2
Regulation
21 CFR 870.1025
Advisory panel
Cardiovascular
Total cleared
2
First cleared
Most recent

FDA classification definition

“Devices are intended to continuously record, display, and/or analyze electrocardiograms of patients in in a healthcare facility for detecting conditions that may require prompt intervention. They may include automatic detection and recording of cardiac electrical activity, automated detection of life-threatening arrhythmias or other relevant conditions, and/or alarm generation. Devices may allow remote access and display of electrocardiograms acquired. Devices are intended for patients who require continuous monitoring in hospitals or healthcare facilities, with onsite medical review by qualified personnel at the central monitoring/analysis station followed by immediate notification of onsite qualified medical responders. Devices may be used for patients at elevated risk of serious cardiovascular events that would require prompt intervention. Devices are intended for prescription use only.”

— U.S. Food and Drug Administration, device classification record for product code QYW under 21 CFR 870.1025, via openFDA

Market context for product code QYW

FDA has cleared 2 devices under product code QYW between 1995 and 2014, filed by 2 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.

Clearances per year

Top applicants under product code QYW

Recent clearances under product code QYW

Data sourced from openFDA. This site is unofficial and independent of the FDA.